emn ukmppd galih
Post on 05-Jul-2018
245 Views
Preview:
TRANSCRIPT
-
8/16/2019 EMN UKMPPD GALIH
1/32
UKMPPD BATCH II
2015 LULUS 100%
-
8/16/2019 EMN UKMPPD GALIH
2/32
SISTEM ENDOKRINE, METABOLIKDAN NUTRISI
• DM tipe 1 4A
• DM tipe 2 4A
•
Hipogi!e"i# $ig#4A• M#&t$i'i ee$gi p$otei4A
• De('ie'i )it#"i 4A
•
De('ie'i Mie$#4A• Hipe$&$i'e"i# 4A
• O*e'it#'4A
-
8/16/2019 EMN UKMPPD GALIH
3/32
DM
• Di#*ete' Meit&' #+## g#gg"et#*oi! -#g +it#+#i oeipe$gi!e"i# #!i*#t +e.e! p#+# !e$/#i'&i $e'i'te'i i'&i +# 'e!$e'ii'&i #t#& !e++-#3
-
8/16/2019 EMN UKMPPD GALIH
4/32
• Hasil Anamnesis (Subjective)
• Ke&#
• 13 Poi.#gi#
• 23 Poi&$i• 3 Poi+ip'i
• 43 Pe&$&# *e$#t *#+# -#g ti+#! /e#' 'e*#*-#
• Ke&# ti+#! !#' DM
• 13 Le"#
• 23 Ke'e"&t# $#'# *## +i &/&g&/&g e!'t$e"it#'
• 3 6#t#
• 43 M#t# !#*&$
• 53 Di'.&g'i e$e!'i p#+# p$i#
• 73 P$&$it&' 8&8#e p#+# 9#it#
• :3 L&!# -#g '&it 'e"*&
-
8/16/2019 EMN UKMPPD GALIH
5/32
• ;#!to$ $i'i!o DM tipe 2
• 13 Be$#t *#+# e*i +# o*e'e IMT < 25 !g="2
• 23 Ri9#-#t pe-#!it DM +i !e$g#
•
3 Meg##"i ipe$te'i TD < 140=>0 ""Hg #t#&'e+#g +##" te$#pi ipe$te'i
• 43 Pe$# +i+i#go'i' pe-#!it /#t&g #t#& 't$o!e!#$+io8#'!&#$
• 53 Koe'te$o HDL ? 5 "g=+ +# = #t#& T$igi'e$i+# @250 "g =+L #t#& 'e+#g +##" pego*#t#+i'ipi+e"i#
• 73 Ri9#-#t "e#i$!# *#-i +eg# BBL @ 4000 g$#"#t#& pe$# +i+i#go'i' DM 6e't#'io#
•
:3 Pe$e"p +eg# $i9#-#t PCOS polycistic ovarysyndrome
• 3 Ri9#-#t 6DPT 6&!o'# D#$# P'# te$g#g& = T6TToe$#'i 6&!o'# Te$g#gg&
• >3 A!ti(t#' /#'"#i -#g !&$#g
-
8/16/2019 EMN UKMPPD GALIH
6/32
• Hasil Pemeriksaan Fisik dan penunjang sederhana(Objective)
• Pe"e$i!'## ;i'i! P#togo"oi'
• Pe&$&# *e$#t *#+# -#g ti+#! /e#' pe-e*#*-#
• ;#!to$ P$e+i'po'i'i
• 13 U'i# @ 45 t#&
• 23 Diet tiggi !#o$i +# e"#!
• 3 A!ti(t#' ('i! -#g !&$#g
• 43 Hipe$te'i TD < 140=>0 ""Hg
• 53 Ri9#-#t toe$#'i g&!o'# te$g#gg& T6T #t#& g&!o'# +#$#p'# te$g#gg& 6DPT
• 73 Pe+e$it# pe-#!it /#t&g !o$oe$, t&*e$!&o'i',ipe$ti$oi+i'"e
• :3 Di'ipi+e"i#
-
8/16/2019 EMN UKMPPD GALIH
7/32
• Pe"e$i!'## Pe&/#g
• 13 6&# D#$# P'#
• 23 6&# D#$# 2 /#" Po't P$#+i#
• 3 H*A1C
• Penegakan Diagnosis ( Assessment )
• Di#go'i' Kii'
• K$ite$i# +i#go'ti! DM +# g#gg toe$#'i g&!o'#
• 13 6e/## !#'i! DM poi&$i#, poi+ip'i#, poi.#gi g&!o'# p#'"#'e9#!t& < 200 "g=+L 1131 ""o=L3 6&!o'# p#'"# 'e9#!t&"e$&p#!# #'i pe"e$i!'## 'e'##t p#+# 't& #$i t#p#"e"pe$#ti!# 9#!t& "#!# te$#!i$3 ATAU
• 23 6e/## K#'i! DM K#+#$ g&!o'# p#'"# p'# < 127 "g=+3 P'#+i#$ti!# p#'ie ti+#! "e+#p#t !#o$i t#"*## 'e+i!it-# /#" ATAU
• 3 K#+#$ g&!o'# p#'"# 2 /#" p#+# te' toe$#'i g&!o'# te$g#gg&TT6O @ 200 "g=+L 1131 ""o=L TT6O +i#!&!# +eg# 't#+#$+HO, "egg&#!# *e*# g&!o'# #i+$&' :5 g$#" -#g +i#$&t!#+##" #i$3 ATAU
• 43 H*A1C Peet +i#go'i' DM *e$+#'#$!# H*A1C < 735 % *e&"+#p#t +ig&#!# 'e#$# #'io# +i I+oe'i#, "egig#t 't#+#$i'#'ipe"e$i!'## -#g "#'i *e&" *#i!3
-
8/16/2019 EMN UKMPPD GALIH
8/32
• Ap#*i# #'i pe"e$i!'## ti+#! "e"e&i !$ite$i#o$"# #t#& DM, "#!# +#p#t +igoog!# !e +##"!eo"po! T6T #t#& 6DPT te$g#t&g +#$i #'i
-#g +ipe$oe• K$ite$i# g#gg toe$#'i g&!o'#
• 13 6DPT +iteg#!!# *i# 'ete# pe"e$i!'##g&!o'# p#'"# p'# +i+#p#t!# #t#$# 100125
"g=+ 53773> ""o=• 23 T6T +iteg#!!# *i# 'ete# pe"e$i!'## TT6O
!#+#$ g&!o'# p#'"# 1401>> "g=+ p#+# 2 /#"'e'&+# *e*# g&!o'# :5 g$#" :3 1131 ""o=L
•
3 H*A1C 53: 734%F Peet +i#go'i' DM*e$+#'#$!# H*A1C < 735 % *e&" +#p#t+ig&#!# 'e#$# #'io# +i I+oe'i#, "egig#t't#+#$i'#'i pe"e$i!'## -#g "#'i *e&" *#i!3
-
8/16/2019 EMN UKMPPD GALIH
9/32
-
8/16/2019 EMN UKMPPD GALIH
10/32
• K#'i(!#'i DM
• I3 DM tipe 1
• DM p#+# &'i# "&+#, ? 40 t#&
• I'&i dependent #!i*#t +e't$&!'i'e
• #3 Immune-mediated
•
*3 I+iop#ti!
• II3 DM tipe 2 *e$8#$i#'i "&#i +#$i -#g p$e+o"i# $e'i'te'i i'&i +eg#+e('ie'i i'&i $e#ti. +o"i# +e.e! 'e!$e'i i'&i +i'e$t#i $e'i'te'i i'&i
• III3 Tipe #i
• #3 De.e! geeti! p#+# .&g'i 'e G
• *3 De.e! geeti! p#+# !e$/# i'&i• 3 Pe-#!it e!'o!$i p#!$e#'
• +3 E+o!$iop#ti
• e3 A!i*#t o*#t #t#& #t !i"i# te$tet& "i'#-# 8acor, pentamidine, nicotinic acid,g&!o!o$ti!oi+, o$"oe ti$oi+, diazoxide, agonis adrenergik, thiazid, phenytoin,interferon, protease inhibitors, clozapine
• .3 I.e!'i
• g3 Bet&! ti+#! #i" +#$i i""&e "e+i#te+ DM
• 3 Si+$o" geeti! #i, -#g !#+#g *e$!#it# +eg# DM
• I)3 DM ge't#'io#
• Di#*ete' Meit&' 6e't#'io# DM6 #+## 't& g#gg toe$#'i !#$*oi+$#tT6T, 6DPT, DM -#g te$/#+i #t#& +i!et#&i pe$t#"# !#i p#+# '##t !e#"i# 'e+#g
*e$#g'&g3
-
8/16/2019 EMN UKMPPD GALIH
11/32
• S!$iig
• Pei#i# #+#-# $i'i!o DM6 pe$& +i#!&!# 'e/#! !&/&g#pe$t#"# &t&! pe"e$i!'## !e#"i#-#3
• ;#!to$ $i'i!o DM6 "eip&ti
• 13 Ri9#-#t DM6 'e*e&"-# #t#& T6T #t#& 6DPT
• 23 Ri9#-#t !e$g# +eg# +i#*ete'
• 3 O*e'it#' *e$#t @120% *e$#t *#+# i+e#
• 43 Ri9#-#t "e#i$!# *#-i +eg# ##t *#9## #t#&
+eg# *e$#t *#+# #i$ @ 4000 g$• 53 A*o$t&' *e$&#g
• 73 Ri9#-#t PCOS Po-i'ti O8#$i S-+$o"e
• :3 Ri9#-#t p$ee!#"p'i#
• 3 6&!o'&$i#
• >3 I.e!'i '#&$# !e"i *e$&#g #t#& !#+i+i#'i'
• P#+# 9#it# #"i -#g "e"ii!i $i'i!o tiggi DM6 pe$&+i#!&!# te' DM6 p#+# "igg& !e24 2 !e#"i#
-
8/16/2019 EMN UKMPPD GALIH
12/32
• Di#go'i'
• Bi# +i+#p#t!# 6DS < 200 "g=+ #t#& 6DP < 127 "g=+ -#g 'e'i +eg# *#t#'+i#go'i' &t&! +i#*ete', "#!# pe$& +i#!&!# pe"e$i!'## p#+# 9#!t& #i &t&!!o($"#'i3 P#'ie #"i +eg# T6T +# 6DPT +i!eo# 'e*#g#i DM63
• Di#go'i' B#+ig
• Di#*ete' i'ipi+&' p#+# i*& #"i
• Ko"pi!#'i
• A3 A!&t
• 13 Keto#'i+o'i' +i#*eti!
• 23 Hipe$o'"o#$ o !etoti!
• 3 Hipogi!e"i#
• B3 K$oi!
•13 M#!$o#giop#ti
• 23 Pe"*&& +#$# /#t&g
• 3 Pe"*&& +#$# pe$i.e$
• 43 Pe"*&& +#$# ot#!
• C3 Mi!$o#giop#ti
• 13 Pe"*&& +#$# !#pie$ $eti#
• 23 Pe"*&& +#$# !#pie$ $e#
• D3 Ne&$op#ti
• E3 6#*&g#
• 13 K#$+io"iop#ti
• 23 Ret# i.e!'i
• 3 K#!i +i#*eti!
• 43 Di'.&g'i e$e!'i
-
8/16/2019 EMN UKMPPD GALIH
13/32
• Penatalaksanaan komprehensif (Plan)
• Pe#t##!'###
• Te$#pi &t&! Di#*ete' Meit&' +i#!&!# +eg# "o+i(!#'i g#-# i+&p +#pego*#t# #go$it"# pegeo## DM tipe 2
• Pe#t##!'### DM6 'e*#i!-# +i#!'##!# 'e#$# te$p#+& oe 'pe'i#i'pe-#!it +##", 'pe'i#i' o*'tet$i gie!oogi', #i +iet, +# 'pe'i#i' ##!3
• T&/ pe#t##!'### #+## "e&$&!# #g!# !e'#!it# +# !e"#ti#i*&, !e'#!it# +# !e"#ti# pe$i#t#3 Ii #-# +#p#t +i#p#i #p#*i#!e#+## o$"ogi!e"i# +#p#t +ipe$t##!# 'e#"# !e#"i# '#"p#ipe$'#i#3
• S#'#$# o$"ogi!e"i# DM6 #+## !#+#$ 6DP >5 "g=+ +# 2 /#"'e'&+# "#!# 120 "g=+3 Ap#*i# '#'#$# g&!o'# +#$# ti+#! te$#p#i
+eg# peg#t&$# "#!# +# #ti# /#'"#i, #g'&g +i*e$i!# i'&i3• I*& #"i +eg# DM6 pe$& +i#!&!# '!$iig DM p#+# 712 "igg& p#'#
"e#i$!# +# '!$iig DM #/&t# &t&! "ei#t pe$!e"*#g# !e #$#DM #t#& p$e+i#*ete'3
-
8/16/2019 EMN UKMPPD GALIH
14/32
-
8/16/2019 EMN UKMPPD GALIH
15/32
-
8/16/2019 EMN UKMPPD GALIH
16/32
• C#$# Pe"*e$i# OHO, te$+i$i +#$i
• 13 OHO +i"&#i +eg# +o'i' !ei +# +itig!#t!#'e#$# *e$t##p'e'i $e'po' !#+#$ g&!o'# +#$#,+#p#t +i*e$i!#'#"p#i +o'i' opti"#3
• 23 S&.oi&$e# 15 0 "eit 'e*e&" "#!#3• 3 Rep#gii+, N#tegii+ 'e'##t 'e*e&" "#!#3
• 43 Met.o$"i 'e*e&"=p#+# '##t='e'&+# "#!#3
• 53 Peg#"*#t g&!o'i+#'e Acarbose *e$'#"# "#!#
'p#pe$t#"#3• 73 Ti#oi+i+io ti+#! *e$g#t&g p#+# /#+9# "#!#3
• :3 DPPI) ii*ito$ +#p#t +i*e$i!# *e$'#"# "#!# +##t#&'e*e&" "#!#3
-
8/16/2019 EMN UKMPPD GALIH
17/32
• Pe"e$i!'## Pe&/#g L#/&t#*i# +ipe$&!#
• U$i#i'i' p$otei&$i +#"i!$o#*&"i&$i#, .&+&'!opi,&$e&", !$e#tii, ipi+ p$o(, EK6,.oto to$#!3
-
8/16/2019 EMN UKMPPD GALIH
18/32
-
8/16/2019 EMN UKMPPD GALIH
19/32
• Ko'eig J E+&!#'i
• E+&!#'i "eip&ti pe"##"# tet#g
• 13 Pe-#!it DM3
• 23 M#!# +# pe$&-# pege+#i# +# pe"#t# DM3
•
3 Pe-&it DM3• 43 Ite$8e'i .#$"#!oogi'3
• 53 Hipogi!e"i#3
• 73 M#'## !&'&' -#g +i#+#pi3
• :3 C#$# "ege"*#g!# 'i'te" pe+&!&g +# "eg#/#$!#
!ete$#"pi#3• 3 C#$# "e"pe$g&#!# .#'iit#' pe$#9#t# !e'e#t#3
• >3 Pe"*e$i# o*#t /#g!# p#/#g +eg# !ot$o te$#t&$'eti#p 2 "igg&=1 *
-
8/16/2019 EMN UKMPPD GALIH
20/32
• Pe$e### M#!#
• St#+#$ -#g +i#/&$!# #+## "#!## +eg# !o"po'i'i
• 13 K#$*oi+$#t 45 75 %
• 23 P$otei 15 20 %
•
3 Le"#! 20 25 %• &"# !#+&g# !oe'te$o +i'#$#!# ? 00 "g=#$i3
Di&'##!# e"#! *e$#'# +#$i '&"*e$ #'#" e"#! ti+#! /e& MU;A Mono Unsaturated Fatty Acid, +# "e"*#t#'iPU;A oly Unsaturated Fatty Acid +# #'#" e"#! /e&3
&"# !#+&g# 'e$#t 25 g=$, +i&t#"#!# 'e$#t #$&t3• &"# !#o$i *#'# pe$ #$i
• 13 L#!i#!i 0 !#=!g BB i+#"#
• 23 #it# 25 !#=!g BB i+#"#
-
8/16/2019 EMN UKMPPD GALIH
21/32
• Pe-e'i# te$#+#p !#o$i *#'# = #$i
• 13 St#t&' gii
• BB ge"&! 20 %
• BB e*i 10 %
• BB !&$#g 20 %
•
23 U"&$ @ 40 t#& 5 %• 3 St$e' "et#*oi! i.e!'i, ope$#'i,+ 10 '=+ 0 %
• 43 A!ti(t#'
• Rig# 10 %
• Se+#g 20 %
• Be$#t 0 %
• 53 H#"i
• t$i"e'te$ I, II 00 !#• t$i"e'te$ III = #!t#'i 500 !#
• R&"&' B$o#F
• Be$#t *#+# i+#"# TB 100 10 %
• !ria " #$% cm dan &anita " #'% cm, tidak dikurangi #% ( lagi)
•
BB !&$#g ? >0 % BB i+#"#• BB o$"# >0 110 % BB i+#"#
• BB e*i 110 120 % BB i+#"#
• 6e"&! @ 120 % BB i+#"#
• L#ti# #'"#i
• Kegi#t# /#'"#i 'e#$i#$i +# #ti# te$#t&$ 4 !#i 'e"igg& 'e#"# !&$#g e*i0 "eit3 Kegi#t# 'e#$i#$i 'epe$ti *e$/## !#!i !e p#'#$, "egg&#!# t#gg#,
*e$!e*&, #$&' tet#p +i#!&!#3
-
8/16/2019 EMN UKMPPD GALIH
22/32
• K$ite$i# R&/&!#
• &t&! pe#g## ti+#! #/&t p#+# !o+i'i*e$i!&t
•
13 DM +eg# !o"pi!#'i• 23 DM +eg# !ot$o g&# *&$&!
• 3 DM +eg# i.e!'i *e$#t
• 43 DM +eg# !e#"i#
• 53 DM t-pe 1• Pe"#t# +# ti+#! #/&t
• 13 E+&!#'i +# "##/e"e &t$i'i
• Be$#t *#+# +i&!&$ 'eti#p !#i !&/&g#
• Pei#i# $&ti !#+&g#, !tit#', +#peg#t&$# 9#!t& #'&p# "#!##3 Di'e'i!#+eg# !e*&t
• T#$get pe&$&# *e$#t *#+# "e&/& *e$#t
*#+# i+e# +# !ot$o g&# +#$# te$#p#i3
-
8/16/2019 EMN UKMPPD GALIH
23/32
• 23 L#ti# ('i!
• Pei#i# #!ti8it#' ('i! p#ig 'e+i!it 'eti#p tig# *&#'e!#i
• Re## #ti# pegg#*&g# +eg# pii#
#!ti8it#' 'e!#$#g ii +# e8e #!ti8it#' +itig!#t!#'#"p#i *#t#' toe$#'i3 Di#/&$!# 150 "eit = "igg&+&$#'i 045 "eit +eg# ite$8# 5 = "igg&+eg# #!ti8it#' ('i! #e$o*i! ite'it#' 'e+#g 50:0%Maximum *eart +ate3
• A!ti8it#' ('i! +i'e'i!# +eg# !o"pi!#'i DM $i'i!ote$/#+i ipogi!e"i#, e&$op#ti pe$i.e$, !#$+io8#'!&#$,$etiop#ti, +# e.$op#ti
• T#$get p#'ie "e#!&!# #!ti8it#' ('i! 'e#$# te$#t&$
-
8/16/2019 EMN UKMPPD GALIH
24/32
• 3 Pe$#9#t# !#!i
• Seti#p !#i p#'ie *e$!&/&g +i#!&!# pe"e$i!'## 8i' !#!i, 'e'i*iit#'e&$op#ti 'e'o$i! , +# 8#'!&#$i'#'i A!e B$#i# I+e= ABI
• E+&!#'i i'pe!'i p$i*#+i 'eti#p #$i +# pe$#9#t# peeg## 'e#$# te$#t&$
•
R&/&!# &t&! pe$#9#t# !&'&', *i# +ipe$&!#• 43 Moito$ig !e"#/ +# #"*#t# pe#t##!'###
• Le"*#$ #t#t# = $e!#"# +i!e"*#g!# &t&! "eig!#t!# pei#i#p#'ie +# !o"&i!#'i pet&g#' !e'e#t# 'e#$# te$&'"ee$&' "oito$ /#/ipe$te", pe"e$i!'## ('i!, i#i #*o$#to$i&", #'i peg&!&$# p$i*#+i g&#+#$#, "#'##"#'## -#g #!ti., pego*#t#, +# #i#i
• St$#tegi "eg#t#'i #"*#t# 1 !ot#! teepo !&/&g# 'e"et#$# 2
"egig#t!# = "egi!&ti = "e"*t /#+9# &#g /#/i pe$te" #!ti8it#''o'i# = e+&!#'i g$&p 4 !#$t& &#p# 'pe'i# = #$i $#-#
• Me&i' #t#t# "ege#i ite$#!'i p#'ie +i+i'!&'i!# +eg# pet&g#'!e'e#t# !ii! &t&! "e/#"i !e#/&t# +# !it#' pe$#9#t#
• D&!&g# !o"&it#' A+#-# +&!&g# !e$g# = o$#g #i -#g petig&t&! "eg#t&$ /#/i pe$te" +# !egi#t# #i3
•
Pe&g#'# 't#. +ipe$&!# &t&! "egopti"#!# ite$#!'i +# pe$#9#t#,'e$t# "eg&$#gi #"*#t# p#'ie
• Pei#i# "##/e"e p$i*#+i 'e#$# te$&'"ee$&' "e-e+i#!# ="e&/&!!# &t&! e+&!#'i DM, +# = #t#& pe+o"# #ti#, +&!&g#p'i!o'o'i#, #t#& '&"*e$ +#-# !o"&it#'3
-
8/16/2019 EMN UKMPPD GALIH
25/32
• 53 Peeg## $etiop#ti = pego*#t#
• Pe"e$i!'## $eti# "#t# +# = #t#& pe"*t#.oto $eti# +i#!&!# 'ege$# 'ete# +i#go'i' DM+iteg#!!# +# +i&#g p#ig 'e+i!it 1 t#& 'e!#i+# e*i 'e$ig *i# #+# $etiop#ti3
• Ut&! "e&$&!# $i'i!o = "e"pe$#"*#tp$og$e'i8it#' $etiop#ti "#!# pe$& "egopti"#!#
!ot$o g&# +#$# +# te!## +#$#• Bi# te$+#p#t $etiop#ti, +i$&/&! !e +o!te$ 'pe'i#i'
"#t#
-
8/16/2019 EMN UKMPPD GALIH
26/32
• 73 Peeg## !#'&' pe-&it
• Te' &t&! "ei#t e!'!$e'i #*&"i &$i +# !$e#tii 'e$&" p#+# DM +i#!&!#p#+# '##t pe$t#"# !#i +i#go'i' DM +iteg#!!#, 'e$t# +i&#g peg&!&$#-#'e#$# $&ti p#ig 'e+i!it 1 t#& 'e!#i3
• Ut&! "e&$&!# $i'i!o = "e"pe$#"*#t p$og$e'i8it#' e.$op#ti "#!# pe$&
"egopti"#!# !ot$o g&# +#$# +# te!## +#$#• P#'ie DM tipe II +eg# Hipe$te'i +# "i!$o#*&"i&$i#, *#i! ACEI = ARB
+#p#t "e"pe$#"*#t p$og$e'i !e "#!$o#*&"i&$i#
• P#'ie DM tipe II +eg# ipe$te'i, "#!$o#*&"i&$i#, +# i'&e'i $e#!$e#tii @ 1,5 *e$i!# ARB &t&! "e"pe$#"*#t p$og$e'i8it#' e.$op#ti3
• Pe"*#t#'# #'&p# p$otei "e/#+i 031 g=!gBB=#$i p#+# DM +eg# 't#+i&"#9# CKD
• Moito$ !$e#tii 'e$&" +# pot#'i&" &t&! "ei#t AR; +# ipe$!#e"i# p#+#pegg&## ACEI, ARB, #t#& ti#i+
• Moito$ e!'!$e'i #*&"i &$i &t&! "ei#t $e'po te$#pi +# p$og$e'i8it#'pe-#!it
• R&/&! !e +o!te$ 'pe'i#i' *i# !#'&' +eg# pe-&it
-
8/16/2019 EMN UKMPPD GALIH
27/32
• :3 M##/e"e ipe$te'i
• Peg&!&$# te!## +#$# 'eti#p !#i !&/&g#
• Bi# TD 'i'toi! < 10 ""Hg = +i#'toi! < 0 ""Hg #$&' +i!o($"#'i&#g +i #$i *e$*e+#, *i# i#i-# < 10=0 +i+i#go'i' ipe$te'i
•
T#$get TD #+## ? 10 = 0 ""Hg• TD 'i'toi! 101> #t#& +i#'toi! 0> ""Hg "o+i(!#'i g#-# i+&p
'e#"# "#!'i"# *&#, *i# t#$get ti+#! te$#p#i, t#"*#!# OAH
• TD 'i'toi! < 140 = +i#'toi! < >0 Q te$#pi OAH "o+i(!#'i g#-# i+&p
• OAH -#g +ig&#!# #+## ACEI = ARB, *i'# /&g# +it#"*#!# HCT+eg# 6;R < 50 "="i pe$ 1,: "2 = oop +i&$eti +eg# 6;R ? 50
"="i pe$ 1,: "2• Te$#pi o*#t "&tipe *i#'#-# +ig&#!# &t&! "e#p#i t#$get TD
• Moito$ 'e#& .&g'i gi/# +# !#+#$ pot#''i&" +#$#
• P#+# p#'ie #"i +eg# DM, t#$get TD 10012> = 75:> ""Hg O*#t-#g +ip#!#i "eti+op#, #*et#o, +iti#e", oi+i, p$#o'ie
-
8/16/2019 EMN UKMPPD GALIH
28/32
• S#$## p$#'#$##
• 13 A#t Pe"e$i!'## 6&# D#$# Se+e$##
• 23 A#t Peg&!&$ *e$#t +# tiggi *#+# ##!
'e$t# +e9#'#• 3 S!## At$opo"et$i
• Prognosis
• P$ogo'i' &"&"-# #+## +&*i#3 K#$e#
pe-#!it ii #+## pe-#!it !$oi', &o #+ 8it#"&"&"-# #+## +&*i# #+ *o#", #"& &o#+ .&g'io#" +# '##tio#"-# #+## +&*i##+ "##"3
-
8/16/2019 EMN UKMPPD GALIH
29/32
• Referensi
• 13 S&+o-o, A33 Seti-o#+i, B3 A9i, I3 Si"#+i*$#t#,M3 Seti#ti, S3E+'3 uku aar ilmu penyakit dalam3E+ 43 )o3 III3 #!#$t# P&'#t Pee$*it# Dep#$te"e
I"& Pe-#!it D##" ;KUI 20073• 23 Pe$!&"p&# E+o!$ioogi I+oe'i#3
.onsensus engelolaan dan encegahan /iabetesMelitus 0ipe 1 di Indonesia) 20113
• 3 Dep#$te"e I"& Ke+o!te$# Ko"&it#' ;KUI+# Pe$'#+i#3 Pe#t##!'### Di#*ete' Meit&'p#+# L#-## P$i"e$, e+32, 2012
-
8/16/2019 EMN UKMPPD GALIH
30/32
-
8/16/2019 EMN UKMPPD GALIH
31/32
• DM tipe #i itoe$#'i g&!#'i #!i*#t pe-#!it #t#& o*#tA
• Hipop#$#ti$oi+ A
• Hipe$ti$oi+ A
• 6oite$ Di'e#'e A• Keto#'i+o'i' +i#*eti!&" o!etoti! B
• Hipe$gi!e"i Hipe$o'"o#$ B
• Hipogi!e"i# Be$#t B
•
Ti$oto!'i!o'i'B• C&'ig' +i'e#'e B
• K$i'i' A+$e# B
• Si+$o" Met#*oi! B
-
8/16/2019 EMN UKMPPD GALIH
32/32
• Ti$oi+iti' 2
• Hipoti$oi+ 2
•
P&*e$t#' p$e!o!' 2• Hipogo#+i'"e 2
• A+eo"# Ti$oi+ 2
•
K#$'io"# Ti$oi+ 2
top related